Artiva Biotherapeutics (ARTV) EBT (2023 - 2026)
Artiva Biotherapeutics' (ARTV) quarterly EBT came in at -$35.2 million in Q1 2026, up 4.46% year-on-year from -$33.7 million in Q1 2025, and down 66.17% on a QoQ basis from -$21.2 million in Q4 2025.
Artiva Biotherapeutics (ARTV) EBT (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of EBT data on file, last reported at -$35.2 million in Q1 2026.
- On a quarterly basis, EBT rose 4.46% year-over-year to -$35.2 million in Q1 2026; TTM through Mar 2026 was -$116.5 million, a 4.44% increase from a year earlier, with the FY2025 full-year figure at -$87.7 million, down 34.2% from the prior year.
- EBT for Q1 2026 stood at -$35.2 million, down from -$21.2 million in the prior quarter.
- Over the last five years, EBT for ARTV reached as high as $11.2 million in Q3 2023 and fell as low as -$36.8 million in Q1 2025.
- Historically, EBT has averaged -$22.0 million across 4 years, with a median of -$23.3 million in 2024.
- Across the five-year window, EBT sank 400.97% in 2024 and jumped 30.87% in 2025, its largest moves.
- Year by year, EBT stood at -$11.6 million in 2023, then tumbled by 100.05% to -$23.2 million in 2024, then climbed by 8.73% to -$21.2 million in 2025, then tumbled by 66.17% to -$35.2 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$35.2 million in Q1 2026, -$21.2 million in Q4 2025, and -$23.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Artiva Biotherapeutics | 249.99 Mn | 249.99 Mn | - | -35.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.20 Mn |
| Dec 31, 2025 | -21.18 Mn |
| Sep 30, 2025 | -23.36 Mn |
| Jun 30, 2025 | -36.75 Mn |
| Mar 31, 2025 | -36.84 Mn |
| Dec 31, 2024 | -23.21 Mn |
| Sep 30, 2024 | -33.80 Mn |
| Jun 30, 2024 | -28.05 Mn |
| Mar 31, 2024 | -13.84 Mn |
| Dec 31, 2023 | -11.60 Mn |
| Sep 30, 2023 | 11.23 Mn |
| Jun 30, 2023 | -11.32 Mn |